Suppr超能文献

形态学FAB分类与免疫表型分析的相关性:对混合性白血病形态学、细胞化学及免疫学特征识别的价值

Correlation of morphological FAB classification and immunophenotyping: value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias.

作者信息

Boban D, Sucić M, Marković-Glamocak M, Uzarević B, Batinić D, Marusić M, Nemet D, Labar B, Hitrec V

机构信息

Department of Clinical Laboratory Diagnosis, Lagreb University School of Medicine and Clinical Center, Croatia.

出版信息

Eur J Cancer. 1993;29A(8):1167-72. doi: 10.1016/s0959-8049(05)80309-0.

Abstract

Correlation between the FAB classification and immunophenotype was studied in 169 consecutive adult patients with acute leukaemia (AL). The lineage of leukaemic cells could be determined in the majority of cases, whereas 3 patients (1.8%) remained unclassified. In 22 out of 71 patients (31%) with acute myeloid leukaemia (AML) FAB M1 and M2 types, and in 5 out of 16 patients (31%) with chronic myeloid leukaemia (CML) in myeloid blast crisis, leukaemic cells did not express myeloid lineage-related markers, indicating asynchronous expression of cell markers in a substantial proportion of patients. Flow cytometric two-colour immunofluorescence revealed mixed AL immunophenotype in 6 out of 169 patients (3.4%). This group included five CD2+AML (5% of AML tested) and one undifferentiated AL expressing CD10(CALLA), CDw65(VIM-2). The former group included FAB M1, M2, M3 and M4 forms of AML with a single cell population, and an AML M2 patient with both cytochemically and immunologically two separate populations of leukaemic cells. This further illustrates the heterogeneity of the target cell(s) for leukaemogenesis and the level of differentiation of AML cells. However, there was no difference in the treatment response and the remission duration between AML patients and patients with mixed phenotype AML.

摘要

对169例连续性成年急性白血病(AL)患者进行了FAB分型与免疫表型之间相关性的研究。大多数情况下可确定白血病细胞的谱系,然而有3例患者(1.8%)仍无法分类。在71例急性髓系白血病(AML)FAB M1和M2型患者中的22例(31%),以及16例处于髓系原始细胞危象的慢性髓系白血病(CML)患者中的5例(31%),白血病细胞未表达髓系谱系相关标志物,表明相当一部分患者中细胞标志物存在异步表达。流式细胞术双色免疫荧光显示169例患者中有6例(3.4%)存在混合性AL免疫表型。该组包括5例CD2+AML(占检测AML的5%)和1例表达CD10(CALLA)、CDw65(VIM-2)的未分化AL。前一组包括具有单一细胞群的FAB M1、M2、M3和M4型AML,以及1例在细胞化学和免疫学上均有两个独立白血病细胞群的AML M2患者。这进一步说明了白血病发生的靶细胞的异质性以及AML细胞的分化水平。然而,AML患者与混合表型AML患者之间的治疗反应和缓解持续时间并无差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验